The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device | Zendy

Astrid van Hylckama Vlieg | Zendy; Frans M. Helmerhorst | Zendy; Frits R. Rosendaal | Zendy

Open Access

The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device

Author(s) -

Astrid van Hylckama Vlieg,

Frans M. Helmerhorst,

Frits R. Rosendaal

Publication year - 2010

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.110.211482

Subject(s) - medicine , levonorgestrel , medroxyprogesterone acetate , venous thrombosis , gynecology , intrauterine device , contraceptive implant , obstetrics , population , thrombosis , hormonal contraception , medroxyprogesterone , family planning , surgery , estrogen , research methodology , environmental health

To assess the risk of venous thrombosis associated with nonoral contraceptives (ie, injectable depot-medroxyprogesterone acetate contraceptives, hormone [levonorgestrel]-releasing intrauterine devices, a contraceptive patch, or a contraceptive implant).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research